A clinical trial of antilymphocyte globulin in renal transplantation. Failure to observe a significant improvement.
D000818:Animals; D000961:Antilymphocyte Serum / Q000009:adverse effects; D001706:Biopsy; D002102:Cadaver; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control*; D000882:Haplorhini; D006650:Histocompatibility Testing; D006736:Horses; D006801:Humans; D007165:Immunosuppression Therapy; D007668:Kidney / Q000187:drug effects / Q000276:immunology; D007677:Kidney Function Tests; D016030:Kidney Transplantation; D011241:Prednisone / Q000008:administration & dosage; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D011241:Prednisone